Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical stage pharmaceutical company. The Company is engaged in the research and development of light, radiation, sound and/or drug-activated small molecule compounds, their associated drug formulations and the light systems that activate them, with a primary objective of efficacy and a secondary objective of safety in the destruction of various cancers, bacteria and viruses. It operates through two divisions: the Drug Division and the Device Division. The Drug Division is responsible for the research and development of light-activated small molecules primarily for the treatment of cancer with assistance from the Device Division to develop medical lasers to activate them. The Device Division is responsible for the Company’s medical laser business, which research, develops, manufactures and distributes cool laser therapy (CLT) systems to healthcare practitioners, predominantly for the healing of pain.


TSXV:TLT - Post by User

Post by Eoganachton Jan 23, 2025 6:02pm
163 Views
Post# 36417919

Not a Shout Out but very indicative of TLD1433's importance

Not a Shout Out but very indicative of TLD1433's importanceDr. McFarland and colleagues' article about the development of TLD1433 is the second most cited paper on photodynamic therapy for bladder cancer out of the 870 papers available on the subject.

Bibliometric analysis of photodynamic research in bladder cancer: trends and future directions

Xi Xu, inshan Xu, Hongliang Gao, Zhaoyang Sheng, Yang Xu, Shuxiong Zeng, Guanghua Chen, Zhensheng Zhang 1
 
Photodiagnosis and Photodynamic Therapy
Available online 22 January 2025

Table 3. Top 10 Cited Documents in Photodynamic Therapy Research for Bladder Cancer. This table showcases the ten most cited documents in the field of photodynamic therapy for bladder cancer. Each entry includes the title of the document, the authors, the journal in which it was published, and the total number of citations. This information is crucial for understanding the foundational studies that have shaped the current landscape of PDT research in bladder cancer.


Rank: 1
Document: Li (2020)
Citations: 2075
Title: Clinical development and potential of photothermal and photodynamic therapies for cancer
Journal: Nature Reviews Clinical Oncology

Rank:2 
Document: Monro (2019)
Citations: 941
Title: Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433
Journal: Chemical Reviews
 
<< Previous
Bullboard Posts
Next >>